Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome

Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome

David C Metz,1 Eric Liu,2 Vijay N Joish,3 Lynn Huynh,4 Todor I Totev,4 Mei Sheng Duh,4 Kiernan Seth,3 Susan Giacalone,3 Pablo Lapuerta,3 Michael A Morse5 1Neuroendocrine Tumor Program at Penn Medicine, Philadelphia, PA 19104, USA; 2The Neuroendocrine Institute at Rocky Mountain Cancer Centers, Denve...

Full description

Bibliographic Details
Main Authors: Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Cancer Management and Research
Subjects:
neuroendocrine tumors
carcinoid syndrome
telotristat ethyl
survival
Online Access:https://www.dovepress.com/survival-and-clinical-outcomes-with-telotristat-ethyl-in-patients-with-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/survival-and-clinical-outcomes-with-telotristat-ethyl-in-patients-with-peer-reviewed-article-CMAR

Similar Items